CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 444 filers reported holding CRISPR THERAPEUTICS AG in Q1 2022. The put-call ratio across all filers is 0.99 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $568,000 | -67.3% | 7,500 | -51.6% | 0.06% | -67.4% |
| Q3 2021 | $1,736,000 | +12.2% | 15,506 | +62.2% | 0.19% | +12.7% |
| Q2 2021 | $1,547,000 | -6.6% | 9,558 | -29.7% | 0.17% | -11.7% |
| Q1 2021 | $1,656,000 | -20.7% | 13,590 | -0.3% | 0.19% | -22.3% |
| Q4 2020 | $2,087,000 | +143.5% | 13,629 | +32.9% | 0.24% | +105.1% |
| Q3 2020 | $857,000 | +9.7% | 10,252 | -3.5% | 0.12% | +1.7% |
| Q2 2020 | $781,000 | +59.1% | 10,625 | -4.0% | 0.12% | +81.2% |
| Q3 2018 | $491,000 | -54.3% | 11,070 | -39.5% | 0.06% | -64.6% |
| Q2 2018 | $1,074,000 | – | 18,285 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 3,608,874 | $160,053,562,000 | 54.44% |
| Abingworth LLP | 1,237,202 | $54,858,000 | 32.62% |
| NEA Management Company, LLC | 2,090,678 | $92,722,000 | 4.00% |
| New Leaf Venture Partners, L.L.C. | 444,708 | $19,723,000 | 3.59% |
| EcoR1 Capital, LLC | 500,000 | $22,175,000 | 2.00% |
| ARK Investment Management | 1,453,590 | $64,467,000 | 1.95% |
| CLOUGH CAPITAL PARTNERS L P | 337,731 | $14,978,000 | 1.41% |
| Casdin Capital, LLC | 220,000 | $9,757,000 | 1.19% |
| Valiant Capital Management, L.P. | 271,700 | $12,050,000 | 1.07% |
| Monashee Investment Management LLC | 110,000 | $4,879,000 | 1.03% |